Nemaura Medical — Investor Presentation (March 2015)

8 slides from Nemaura Medical's investor presentation, Mar 23, 2015

Slide 1: Contents: Our Background to Contact Details
3 Our Background 5 Our Core Business 6 Management Overview 7 Government Support 8 Our Patents 9 Our First Product - sugarBEAT™ 15 Our Technology 16 Our Clinical trials 17 Regulatory Approval 18 Target Market Analysis 19 Competition 21 Commercialization Process 22 Production and Operations 23 Sales &
Slide 2: 9.0 tel
82 61 9.0 72 122 tel Omer Worcs Na, ] oe =
Slide 3: sugarBEAT product: how it works
1. Affix Patch 5. Transfer Data 2. Extract Glucose 5. Data from app sent over internet to Virtual Health Care Team 2. Patch extracts glucose using Reverse lontophoresis sugarBEAT™ product 4. Display Results 3. Measure Glucose Level - 4. App on 3. Device Smart phone reads glucose shows levels, and re
Slide 4: Slide 4
Slide 5: Slide 5
Slide 6: Correlation Plot - Analysis
SetA 600 500 4 4 Correlation Plot - Analysis‘1 (x1179) 500 100 200 sets (52) 400
Slide 7: Worldwide diabetes prevalence
There is a diabetes - related death every 7 seconds. WORLD Africa Western Pacific Middle East and North 46.3% undiagnosed — WORLD 387M people living with diabetes PREVALENCE 8.3% expected increase +205 MILLION 386,667,280 51,978,310 36,790,040 137,813,470
Slide 8: Sales and Distribution
d Distribution % Advertising % network and Sales » 4 and resources, . resources , y available { Partner Criteria Business plan